How Is Ovarian Cancer Diagnosed?

This content has been reviewed and approved by

Maurie Markman, MD
Vice President, Clinical Research
MD Anderson Cancer Center
University of Texas
 

To diagnose ovarian cancer, your physician may order diagnostic tests, including:

  • Computed tomography (CT or CAT scan) - a noninvasive procedure that takes cross-sectional images of the internal organs to detect any abnormalities that may not show up on an ordinary x-ray. The CT scan may find enlarged lymph nodes—a possible sign of a spreading cancer or of an infection.
  • Lower gastrointestinal (GI) series - x-rays of the colon and rectum using a contrast medium called barium.
  • Intravenous pyelogram (IVP) - x-ray of the kidneys and ureters taken after the injection of a dye.
  • Biopsy - a procedure in which tissue samples are removed from the body for examination under a microscope to determine if cancer or other abnormal cells are present. The diagnosis of cancer can only be confirmed by a biopsy.

Accurate surgical evaluation is necessary for nearly all patients with ovarian cancer. This can be accomplished during either a laparotomy (a procedure in which an incision is made in the abdomen to expose the abdominal contents for diagnosis or surgery) or a laparoscopy (a less invasive procedure in which a viewing device is inserted into the abdominal cavity and biopsies are taken) to determine the stage of the cancer.

This content was last modified on July 23, 2007 .
Latest Ovarian Cancer News
Australian scientists plan to regrow breasts after cancer

November 12, 2009 — SYDNEY (Reuters) - Australian scientists have developed a surgical technique that may allow cancer-suffering women to regrow their breasts after having a mastectomy, with human trials planned to start within three to six months.

Hormone therapy may up risk of dying of lung cancer

September 21, 2009 — NEW YORK (Reuters Health) - Among women who already have lung cancer, hormone replacement therapy - which has been tied to a higher risk of serious conditions including breast cancer and heart attacks - seems to increase the risk of death from the tumor, according to a new study.

New pill shows promise in hard-to-treat cancers

September 3, 2009 — CHICAGO (Reuters) - An experimental cancer pill shrank tumors in patients whose skin cancer had spread, raising hope for a new class of drugs that may have an affect on many other cancers as well, U.S. researchers said on Wednesday.

Select news items provided by Reuters Health